Comparing two pain relief methods for hip surgery
Analgesic Efficacy of Fascia Iliaca Compartment Block Compared With Intrathecal Nalbuphine for Hip Surgery Under Spinal Anesthesia: a Randomized Controlled Trial
This study is testing which pain relief method, a fascia iliaca block or a spinal injection of nalbuphine, works better for people recovering from hip surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 21 Years and up |
| Sex | All |
| Sponsor | Ain Shams University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06818396 on ClinicalTrials.gov |
What this trial studies
This study compares the effectiveness of fascia iliaca compartment block (FICB) and intrathecal nalbuphine for managing postoperative pain in patients undergoing hip surgery under spinal anesthesia. Both methods are known for their efficacy in pain control, and this trial aims to determine which approach provides better analgesic outcomes. Participants will receive either the FICB or intrathecal nalbuphine, alongside spinal anesthesia, to evaluate their pain relief effectiveness post-surgery.
Who should consider this trial
Good fit: Ideal candidates are adults aged 21 and older with an ASA score of I or II and a body mass index under 35 kg/m2.
Not a fit: Patients with known coagulopathy, peripheral neuropathy, neurological deficits, or allergies to the study drugs may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for patients undergoing hip surgery.
How similar studies have performed: Previous studies have shown both methods to be effective, but this specific comparison is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) score (ASA I- ASA II). * Age ≥ 21years. * Body mass index \< 35 kg/m2 Exclusion Criteria: * Patient's refusal. * Known coagulopathy. * Known peripheral neuropathy or neurological deficits. * Known allergy to study drugs
Where this trial is running
Cairo
- Ain-Shams University Hospitals — Cairo, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.